2011, Number 2
<< Back Next >>
Mediciego 2011; 17 (2)
Dobutamine stress echo in the diagnosis of ischemic heart disease.
Sánchez EL, Sánchez MR, Mayola AC
Language: Spanish
References: 10
Page:
PDF size: 35.32 Kb.
ABSTRACT
It was carried out 105 dobutamine stress echo study in the period from August 2008 to
September 2010 at the Diagnostic Medical Center of High Technology “José Martí” from
Barcelona City, Anzoátegui State, Venezuela, in the Cuban medical mission. From 105
patients studied, 70 (66%) were male and 35 (34%) were female; 88 (83%) of these
patients presented chest pain and 17 patients (16%) went for viability diagnosis. From the
105 studies, 32 (30.5%) were positive, and 73 (69.5%) were negative. From the 32 positive
cases, 25 (78.2%) were male and 7 (21.8%) female. 18 patients resulted positive with
negative stress test.
REFERENCES
Cuenca G, Melgarejo I, Pérez J, Blanco M. Primer consenso nacional de ecocardiografía de estrés. Rev Col Cardiol. 2002;10:105-84.
Guías de práctica clínica de la Sociedad Española de Cardiología. Rev Española Cardiol. 2009; 53:1063-94.
Rodgers GP, Ayanian JZ, Balady G, Beasley JW, Brown KA, Gervino EV, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on Stress Testing. A report of the American College of Cardiology/American Heart Association/American College of Physicians. American Society of Internal Medicine Task Force on Clinical Competence. J Am Coll Cardiol. 2000;36:1441-53.
Mathias Junior W, Arruda AM, Benevides H, Duprat R, Andrade JL, Campos Filho O, et al. Expedito acurácia diagnóstica da ecocardiografia com estresse pela dobutamina associada à atropina. Arq Bras Cardiol, 1997; 68:407-13.
Farray Bergés D, Pascal Ricart C, Báez Hernández A, Almonte C, Bello Ortiz S. Ecocardiografía de stress con dobutamina: comparación de su eficacia con la prueba de esfuerzo convencional. Acta Med Dominic. 1997; 19:175-81.
Marwick T, D'Hondt AM, Baudhuin T, Wilemart B, Wijns W. Detry JM, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both. J Am Coll Cardiol. 2010; 22:159-67.
Nagel E, Lehmkuhl HB, Bocksch WM, Klein C, Vogel V, Frantz E, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress chocardiography. Circulation. 2009;99:763-70.
Mathias W, Arruda A, Santos FC, Arruda AL, Mattos E, Osorio A, et al. Safety of dobutamine-atropine stress echocardiography: prospective experience of 4,033 consecutive studies. J Am Soc Echocardiography. 2008;10:785-91.
Mathias W, Stella U, Baruta F, Cordovil A, Andrade JL, Carvalho AC, et al. Prognostic value of stress echocardiography by dobutamine with atropine. Arch Bras Cardiol. 2007; 69:95-9.
Sicari R, Landi P, Picano E, Pirelli S, Chiaranda G, Previtali M, et al. Exerciseelectrocardiography and/or pharmacological stress echocardiography non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. Eur Heart J. 2002; 23:1030-7.